Financial Contrast: Biotricity (NASDAQ:BTCY) and Inari Medical (NASDAQ:NARI)

Biotricity (NASDAQ:BTCYGet Free Report) and Inari Medical (NASDAQ:NARIGet Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Biotricity and Inari Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biotricity 0 1 0 0 2.00
Inari Medical 0 2 5 0 2.71

Inari Medical has a consensus target price of $65.71, suggesting a potential upside of 42.45%. Given Inari Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Inari Medical is more favorable than Biotricity.

Valuation and Earnings

This table compares Biotricity and Inari Medical’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Biotricity $9.64 million 1.00 -$18.66 million ($1.39) -0.73
Inari Medical $520.66 million 5.15 -$1.64 million ($0.41) -112.51

Inari Medical has higher revenue and earnings than Biotricity. Inari Medical is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

3.9% of Biotricity shares are owned by institutional investors. Comparatively, 91.0% of Inari Medical shares are owned by institutional investors. 20.5% of Biotricity shares are owned by insiders. Comparatively, 10.6% of Inari Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Volatility & Risk

Biotricity has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Comparatively, Inari Medical has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500.

Profitability

This table compares Biotricity and Inari Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biotricity -125.43% N/A -233.67%
Inari Medical -4.54% -1.65% -1.23%

Summary

Inari Medical beats Biotricity on 10 of the 13 factors compared between the two stocks.

About Biotricity

(Get Free Report)

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

About Inari Medical

(Get Free Report)

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.